Point of Care Diagnostics Market PPT
                     Point of Care Diagnostics Market 
Point of Care Diagnostics Market Forecast 
to 2028 - COVID-19 Impact and Global 
Analysis By Product (Glucose Monitoring 
Products, Infectious Disease Testing 
Products, Cardiometabolic Testing 
Products, Pregnancy and Fertility Testing 
Products, Coagulation Testing Products, 
Tumor/Cancer Marker Testing Products, 
Cholesterol Testing Products, Urinalysis 
Testing Products, Hematology Testing 
Products, and Other POC Products), 
Prescription Mode (Prescription-Based 
Testing and OTC Testing), and End User 
(Professional Diagnostic Centers, Home 
Care, Research Laboratories, and Others), 
and Geography
Point of Care Diagnostics Market  
Current and future Market Scenario
 According to our new research study on “Point of Care Diagnostics Market Forecast to 2028 – COVID-19 Impact and 
Global Analysis – by Product, Prescription Mode, and End User,” the market is expected to reach US$ 82,958.3 million by 
2028 from US$ 36,000.4 million in 2021.
8
 The market is estimated to grow with a CAGR of 12.7 % from 2021-2028. The report highlights trends prevailing in the 
market, and the factors driving and hindering the market growth. 
Certain factors such as sudden rise in coronavirus infections and exponential growth in COVID-19 diagnostic kits played a 
prominent role in the growth of the point of care diagnostics market during the pandemic. In 2020, the prescription-
based testing segment held a larger share of the market and is expected to register a higher CAGR during the forecast 
period.
 This segment is also expected to dominate the market in 2027. The growth of this segment is mainly attributed to the 
increasing incidence and prevalence of lifestyle diseases and the lack of awareness on OTC POCT devices in developing 
nations.
Key Findings
 The point of care diagnostics market is witnessing substantial growth amid the COVID-19 pandemic. Certain factors 
such as sudden rise in coronavirus infections and exponential growth in COVID-19 diagnostic kits played a prominent 
role in the growth of the point of care diagnostics market during the pandemic.
  factors such as sudden rise in coronavirus infections and exponential growth in COVID-19 diagnostic kits played a 
prominent role in the growth of the point of care diagnostics market during the pandemic. In addition, the growing 
demand for rapid test kits for faster diagnosis at public places is also estimated to have positive impact on the market 
growth.
Market Insights
Increase In Prevalence of Infectious Diseases 
Point of care testing (POCT) is described as medical diagnostic testing at or near the point of care that is, at time and place 
of patient care. The purpose of POCT is to provide immediate information to physicians about the patient's condition. For 
instance, in June 2019, Abbott launched first-ever rapid POC HbA1c test to aid in the diagnosis of diabetes; this test 
provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient 
consultation. Moreover, in July 2021, BD announced launch of rapid and portable point-of-care antigen test for diagnosis 
of COVID-19. The new test kit is capable to deliver results within 15 minutes of the test.
Point of Care Diagnostics Market  
Market Segments
By Product (Glucose Monitoring 
Products, Infectious Disease Testing  
Products, Cardiometabolic Testing 
End User (Professional Diagnostic 
Products, Pregnancy and Fertility Prescription Mode 
Centers, Home Care, Research 
Testing Products, Coagulation (Prescription-Based Testing Laboratories, and Others), and 
Testing Products, Tumor/Cancer and OTC Testing) Geography
Marker Testing Products, Urinalysis 
Testing Products, Hematology 
Testing Products, and Other POC 
Products)
Point of Care Diagnostics Market 
Dominating Segments
 
 Hemophilia is a condition where blood does not clot, and this condition is normally inherited. The condition is 
  caused due to defects in a gene of the X chromosome, which is a clotting factor. Generally, the diseases are 
widely seen in males as the X chromosome is inherited from mother to baby boy.
 The disease is widely treated with replacement therapy and gene therapy. The other treatment which is used 
is medication. However, there are ways to reduce the risk of the condition, which include regular exercise and 
others. The condition can be prevented by taking preventive treatment by injection of clotting factor VIII for 
hemophilia A, or IX for hemophilia B.
 In Italy, according to the data of the National Center for Biotechnology Information (NCBI) in 2017, the 
number of registered people with bleeding disorders increased from about 7000 in 2000 to around 8500 in 
2011 and more than 11,000 in 2015. The trend is due to an upsurge in the number of patients who are 
recorded, mainly in those with vWD type 1, mild hemophilia, or other factor deficiencies.
Dominating Segments
Product Insights
Products Insights
 The use of point of care testing has steadily increased over the last 40 years since its widespread introduction. New 
technologies or products are being refined and improved to deliver easier to use devices with incremental 
improvements in analytical performance.
 The growth of the POC market is mainly attributed to the introduction of new devices to perform molecular 
testing. Many new devices have been launched in recent years. For instance, in June 2019, Abbott launched first-
ever rapid POC HbA1c test to aid in the diagnosis of diabetes; this test provides results in three minutes, enabling 
clinicians to develop informed, individualized care plans during patient consultation.
 Download PDF Brochure https://www.theinsightpartners.com/sample/TIPRE00006394/?source=others-10389 
Dominating Segments
The report segments point of care diagnostics market as follows:
 
By Product
Glucose Monitoring
Infectious Disease Testing
HIV Testing
Influenza Testing
Sexually Transmitted Disease (STD) Testing
Hepatitis C Testing
Healthcare-Associated Infection (HAI) Testing
Tropical Disease Testing
Respiratory Infection Testing
Other Infectious Disease Testing
Cardiometabolic Testing
Pregnancy and Fertility Testing
Coagulation Testing
Dominating Segments
Tumor/Cancer Marker Testing
Cholesterol Testing
Urinalysis Testing
Hematology Testing
Other POC Products
By Prescription Mode
Prescription-Based Testing
OTC Testing
By End User
Professional Diagnostic Centers
Hospitals
Clinical Laboratories
Outpatient Healthcare
Ambulatory Care Settings
Home Care
Research Laboratories
Others
Point of Care Diagnostics Market  
Leading Players
Company Profiles in Point of Care Diagnostics Market are:
F. HOFFMANN-LA ROCHE LTD.
Danaher
BIO-RAD LABORATORIES INC.
Abbott
Johnson and Johnson Services, Inc.
Siemens AG
BD
BioMerieux SA
Polymer Technology Systems, Inc. (PTS)
Nova Biomedical
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
 Point of Care Diagnostics Market  
 
 
 Point of Care Diagnostics Market  
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/point-of-care-diagnostics-market?source=other-10389  
 
Thank You! 
Thank You!